top of page
Supported projects
IMISCA Therapeutics
Developing a patented smart hydrogel combining an immunological adjuvant and a cytokine to treat advanced and metastatic “cold” tumours.
PSCC's entrance
Décembre 2025
Localization
FR - Île-de-France
Modality
Immunotherapy
Development status
Pre-IND/Pre-CTA
Lauréat (s)
bottom of page